Expert Insight - Global Molecular Diagnostics Market
BIS Healthcare Analysts in conversation with: Dr. Shivaji K Jadhav Head of Molecular Biology at Orchard Healthcare Private Limited (Orange Health) and Dr. Ashutosh Shukla Team Leader & Senior Clinical Research Scientist at Patanjali Research Institute
BIS Research provides premium market intelligence on deep technologies that have the potential to cause a high level of disruption in the market in the next few years. We excel in conducting market viability analysis for technologies that are still in the nascent stages of their lifecycle.
For each topic that we cover, BIS Research’s analysts interact with dozens of industry experts to scan, analyze, and predict the future of the concerned technology and its market. Our ‘Expert Insight’ series is one such initiative, where we make the industry insights available to senior executives in a short and quick to read format.
The global molecular diagnostics market is expected to witness robust growth owing to an increasing number of global companies attempting to tap into the vast potential of this market. With an increasing number of companies attempting to establish synergies in order to enter the market and an increasing number of products acquiring approvals from regulatory bodies, this market will witness tremendous dynamicity.
The global molecular diagnostics market has witnessed significant growth, attributing to the increasing demand for multiple biomarkers based-molecular diagnostics. The developments have been instrumental in improving the quality of life and reducing the cost and time of treatment, boosting the growth of the overall healthcare diagnostics market. Further, the increasing awareness and adoption of the precision medicine approach in developed as well as developing countries is the key driver for the growth of the global molecular diagnostics market.
BIS Healthcare Analysts in conversation with: Dr. Shivaji K Jadhav Head of Molecular Biology at Orchard Healthcare Private Limited (Orange Health) and Dr. Ashutosh Shukla Team Leader & Senior Clinical Research Scientist at Patanjali Research Institute
BIS Research provides premium market intelligence on deep technologies that have the potential to cause a high level of disruption in the market in the next few years. We excel in conducting market viability analysis for technologies that are still in the nascent stages of their lifecycle.
For each topic that we cover, BIS Research’s analysts interact with dozens of industry experts to scan, analyze, and predict the future of the concerned technology and its market. Our ‘Expert Insight’ series is one such initiative, where we make the industry insights available to senior executives in a short and quick to read format.
The global molecular diagnostics market is expected to witness robust growth owing to an increasing number of global companies attempting to tap into the vast potential of this market. With an increasing number of companies attempting to establish synergies in order to enter the market and an increasing number of products acquiring approvals from regulatory bodies, this market will witness tremendous dynamicity.
The global molecular diagnostics market has witnessed significant growth, attributing to the increasing demand for multiple biomarkers based-molecular diagnostics. The developments have been instrumental in improving the quality of life and reducing the cost and time of treatment, boosting the growth of the overall healthcare diagnostics market. Further, the increasing awareness and adoption of the precision medicine approach in developed as well as developing countries is the key driver for the growth of the global molecular diagnostics market.